Mumbai, INDIA
+91 22-2581-7000
+91 22-2581-7002

FEMIPRISTAL

THE FIRST ORAL NON-INVASIVE LONG TERM TREATMENT OPTION FOR UTERINE FIBROID

 

Ulipristal acetate is a potent Anti-progesterone which acts on
• Fibroids
• Inhibition of cell proliferation
• Induction of apoptosis
• Reduces fibroid size
• Endometrium
• Stops uterine bleeding
• Results in benign and reversible changes
• Results in amenorrhea
• Pituitary HPO Axis
• Decreases LH & FSH
• Maintaining mid-follicular phase levels of estradiol (60-150 pg/ml)
• Inhibits ovulation

TRANSFORMING THE MANAGEMENT OF UTERINE FIBROID WITH LONG-TERM USE OF FEMIPRISTAL
Femipristal provides:
• Fast, reliable and sustained bleeding control
• Significant and sustained reductions in fibroid volume
• Improved quality of life, to the level of healthy subjects
• Efficacy on fibroid and associated symptom maintenance during off-treatment periods
• Safe treatment for long-term symptom management – repeated treatment courses did not increase the occurrence of adverse events

Femipristal is an oral Selective Progesterone Receptor Modulator (SPRM) specifically designed to treat symptoms of uterine fibroids.

Ulipristal acetate (5mg)

1×10 Capsules

• Long term Intermittent treatment of moderate to severe symptoms of Uterine Fibroid in adult women of reproductive age
• Preoperative treatment of moderate to severe symptoms of Uterine Fibroid in adult women of reproductive age

Related Posts